Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease: A Prospective, Randomized, Open-Label, Parallel-Group, Multicenter Study

NCT07239570 is registered in ClinicalTrials.gov with Peter Rossing as lead sponsor.

NCT NCT07239570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07239570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease: A Prospective, Randomized, Open-Label, Parallel-Group, Multicenter Study
Lead sponsor
Peter Rossing
Phase
Phase 4
Overall status
Recruiting
Start date
June 20, 2025
Completion date
June 30, 2028
Enrollment
125 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease(ckd)